E
ETON PHARMACEUTICALS INC
NASDAQ: ETON (Eton Pharmaceuticals, Inc.)
Last update: 1 hour ago52.18
-1.49 (-2.78%)
| Previous Close | 53.67 |
| Volume | 333,692 |
| Price / Earnings (Forward) | 22.43 |
| Price / Sales | 14.62 |
| Price / Book | 31.66 |
| 52 Weeks Range |
| Profit Margin | -9.48% |
| Operating Margin (TTM) | -2.72% |
| Diluted EPS (TTM) | -0.180 |
| Quarterly Revenue Growth (YOY) | 116.90% |
| Total Debt/Equity (MRQ) | 123.34% |
| Current Ratio (MRQ) | 1.97 |
| Operating Cash Flow (TTM) | 5.53 M |
| Levered Free Cash Flow (TTM) | -14.13 M |
| Return on Assets (TTM) | -2.02% |
| Return on Equity (TTM) | -22.95% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Eton Pharmaceuticals, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -1.3 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | -2.2 |
| Macro Environment | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -1.03 |
Select this tab to load the latest available analysis.
|
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Growth |
| % Held by Insiders | 4.39% |
| % Held by Institutions | 53.50% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Opaleye Management Inc. | 30 Jun 2026 | 2,860,000 |
| Ecor1 Capital, Llc | 30 Jun 2026 | 2,171,938 |
| Nantahala Capital Management, Llc | 30 Jun 2026 | 1,175,951 |
| Oberweis Asset Management Inc/ | 30 Jun 2026 | 501,600 |
| National Philanthropic Trust | 30 Jun 2026 | 492,112 |
| Westside Investment Management, Inc. | 30 Jun 2026 | 431,160 |
| Pillsbury Lake Capital Llc | 30 Jun 2026 | 387,157 |
| Nuveen, Llc | 30 Jun 2026 | 375,707 |
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |